Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Jul 29, 2026, 15:00 ET Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE
Greenberg Traurig, P.A. advised Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides, in connection with its oversubscribed $275 million private placement financing.
More news about: Greenberg Traurig, LLP
Apr 06, 2026, 13:50 ET Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners
Greenberg Traurig, P.A. advised Israel-based Entera Bio Ltd. (Nasdaq: ENTX), a clinical-stage biotechnology company focused on the development of oral peptide and protein replacement therapies, in a $10 million private placement
More news about: Greenberg Traurig, LLP